Marianna Adamo to Humans
This is a "connection" page, showing publications Marianna Adamo has written about Humans.
Connection Strength
0.074
-
June 2020 at a glance: focus on COVID-19, quality of life and comorbidities. Eur J Heart Fail. 2020 06; 22(6):917-918.
Score: 0.007
-
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail. 2019 02; 21(2):196-204.
Score: 0.006
-
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less. Am J Cardiol. 2018 11 15; 122(10):1718-1726.
Score: 0.006
-
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: early and midterm outcomes. EuroIntervention. 2017 Oct 13; 13(9):e1032-e1039.
Score: 0.006
-
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. Int J Cardiol. 2017 May 01; 234:53-57.
Score: 0.006
-
[Bioequivalence and excipients: the case of tirofiban. A warning from the Italian Society of Interventional Cardiology (SICI-GISE)]. G Ital Cardiol (Rome). 2017 Feb; 18(2 Suppl 1):35S-36S.
Score: 0.006
-
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry. Int J Cardiol. 2021 06 01; 332:227-234.
Score: 0.002
-
March 2021 at a glance: focus on epidemiology, prevention and COVID-19. Eur J Heart Fail. 2021 03; 23(3):347-349.
Score: 0.002
-
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy. Eur J Heart Fail. 2021 03; 23(3):486-488.
Score: 0.002
-
Association of social containment on ST-segment elevation myocardial infarction presentations during the COVID-19 pandemic. Coron Artery Dis. 2021 01; 32(1):1-3.
Score: 0.002
-
December 2020 at a glance: focus on COVID-19, comorbidities and palliative care. Eur J Heart Fail. 2020 12; 22(12):2173-2174.
Score: 0.002
-
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2020 Nov; 21(11):874-881.
Score: 0.002
-
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19. Eur Heart J. 2020 09 01; 41(33):3200.
Score: 0.002
-
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020 Jun; 22(6):941-956.
Score: 0.002
-
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 07 01; 5(7):819-824.
Score: 0.002
-
Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk? Eur Heart J. 2020 07 01; 41(32):3094.
Score: 0.002
-
COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020 Jun; 22(6):957-966.
Score: 0.002
-
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 05 14; 41(19):1821-1829.
Score: 0.002
-
Comparison of intra-procedural vs. post-stenting prolonged bivalirudin infusion for residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing: the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study. Eur Heart J Cardiovasc Imaging. 2019 Dec 01; 20(12):1418-1428.
Score: 0.002
-
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? Eur J Heart Fail. 2019 07; 21(7):852-861.
Score: 0.002
-
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis. J Cardiovasc Med (Hagerstown). 2019 Mar; 20(3):131-136.
Score: 0.002
-
Incidence, Technical Safety, and Feasibility of Coronary Angiography and Intervention Following Self-expanding Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2019 05; 20(5):371-375.
Score: 0.002
-
A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients. ESC Heart Fail. 2018 12; 5(6):1150-1158.
Score: 0.002
-
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation. Eur J Heart Fail. 2018 10; 20(10):1495-1496.
Score: 0.002
-
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy. Int J Cardiol. 2018 Oct 15; 269:33-39.
Score: 0.002
-
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study. BMJ Open. 2017 Sep 05; 7(9):e016909.
Score: 0.001
-
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction. Am J Cardiol. 2017 Nov 01; 120(9):1639-1647.
Score: 0.001
-
Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: A case-matched comparison. Int J Cardiol. 2017 Sep 15; 243:126-131.
Score: 0.001